- Home
- INSM vs AWK Comparison
INSM vs AWK Comparison
Compare INSM & AWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSM
- AWK
- Stock Information
- Founded
- INSM 1988
- AWK 1886
- Country
- INSM United States
- AWK United States
- Employees
- INSM N/A
- AWK N/A
- Industry
- INSM Biotechnology: Pharmaceutical Preparations
- AWK Water Supply
- Sector
- INSM Health Care
- AWK Utilities
- Exchange
- INSM Nasdaq
- AWK Nasdaq
- Market Cap
- INSM 26.0B
- AWK 27.5B
- IPO Year
- INSM 2000
- AWK 2008
- Fundamental
- Price
- INSM $145.10
- AWK $143.60
- Analyst Decision
- INSM Strong Buy
- AWK Hold
- Analyst Count
- INSM 19
- AWK 11
- Target Price
- INSM $142.38
- AWK $144.45
- AVG Volume (30 Days)
- INSM 3.0M
- AWK 1.2M
- Earning Date
- INSM 10-30-2025
- AWK 10-29-2025
- Dividend Yield
- INSM N/A
- AWK 2.31%
- EPS Growth
- INSM N/A
- AWK 13.50
- EPS
- INSM N/A
- AWK 5.55
- Revenue
- INSM $398,105,000.00
- AWK $4,942,000,000.00
- Revenue This Year
- INSM $32.47
- AWK $7.22
- Revenue Next Year
- INSM $126.03
- AWK $6.07
- P/E Ratio
- INSM N/A
- AWK $25.87
- Revenue Growth
- INSM 21.15
- AWK 13.38
- 52 Week Low
- INSM $60.40
- AWK $118.74
- 52 Week High
- INSM $146.84
- AWK $155.50
- Technical
- Relative Strength Index (RSI)
- INSM 79.86
- AWK 51.24
- Support Level
- INSM $128.02
- AWK $139.81
- Resistance Level
- INSM $146.84
- AWK $144.54
- Average True Range (ATR)
- INSM 3.66
- AWK 1.96
- MACD
- INSM 0.71
- AWK -0.35
- Stochastic Oscillator
- INSM 91.65
- AWK 47.02
About INSM Insmed Incorporated
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.
About AWK American Water Works Company Inc.
American Water Works is the largest investor-owned US water and wastewater utility, serving approximately 3.5 million customers in 16 states. It provides water and wastewater services to residential, commercial, and industrial customers and operates predominantly in regulated markets. The company's nonregulated business is water services for military bases, which operates under long-term contracts with regulated-like returns.